Image from Google Jackets

Iatrogenicity : Causes and Consequences of Iatrogenesis in Cardiovascular Medicine [E-Book]

Contributor(s): Publisher: New Brunswick, New Jersey : Rutgers University Press Medicine, 2018Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780813586434
  • 0813586437
Subject(s): Online resources:
Contents:
Intro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs
Chapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics
Chapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults
Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy
Chapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index
Summary: "Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. . "-- Provided by publisher.
List(s) this item appears in: Cardiology
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Online resource; title from PDF title page (EBSCO, viewed March 29, 2018).

Includes bibliographical references and index.

"Iatrogenesis is the occurrence of untoward effects resulting from actions of health care providers, including medical errors, medical malpractice, practicing beyond one's expertise, adverse effects of medication, unnecessary treatment, inappropriate screenings, and surgical errors. This is a huge public health issue: tens to hundreds of thousands of deaths are attributed to iatrogenic causes each year in the U.S., and vulnerable populations such as the elderly and minorities are particularly susceptible. Edited by two renowned cardiology experts, Iatrogenicity: Causes and Consequences of Iatrogenesis in Cardiovascular Medicine addresses both the iatrogenicity that arises with cardiovascular interventions, as well as non-cardiovascular interventions that result in adverse consequences on the cardiovascular system. The book aims to achieve three things: to summarize the available information on this topic in a single high-yield volume; to highlight the human and financial cost of iatrogenesis; and to describe and propose potential interventions to ameliorate the effects of iatrogenesis. This accessible book is a practical reference for any practicing physician who sees patients with cardiovascular issues. . "-- Provided by publisher.

Intro; Title Page; Copyright; Contents; Contributors; The Concept of Iatrogenicity; Part I: Medical Harm; Chapter 1. Iatrogenicity: Definition, History, and Modern Context; Chapter 2. Epidemiology and Public Health Aspects and Implications of Iatrogenicity: Regulatory, Legal and Ethical Dimensions; Chapter 3. Risk Management: The Medical Center Administration Perspective; Chapter 4. Iatrogenicity from the Patient's Perspective; Chapter 5. A Naturopathic Perspective on Iatrogenesis; Part II: Iatrogenicity of Cardiovascular Drugs and Cardiovascular Toxicity of Noncardiac Drugs

Chapter 6. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and SyndromesChapter 7. Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death; Chapter 8. Chemotherapy-Induced Cardiomyopathy; Chapter 9. Iatrogenicity of Blood Pressure Measurement in the Diagnosis of Hypertension; Chapter 10. Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes; Chapter 11. Iatrogenicity of Cardiovascular Drugs Associated With Cardiac and Noncardiac Toxicities: Antihypertensive Agents and Biologics

Chapter 12. Iatrogenic Aspects of Hypertension in Pregnancy: Focus on PreeclampsiaChapter 13. Women and Iatrogenic Cardiovascular Disease: Menopausal Estrogen as the Prime Suspect; Chapter 14. Iatrogenic Aspects of Lipid-Lowering, Antiplatelet, and Anticoagulant Agents; Chapter 15. Iatrogenic Effects of Urologic Drugs on the Cardiovascular System; Chapter 16. Iatrogenicity and Antianginal Drugs; Chapter 17. Antidiabetic Drugs and Cardiovascular Risk: Where Do We Stand?; Chapter 18. Cardiovascular Iatrogenicity in Older Adults

Part III: Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and SurgeriesChapter 19. Iatrogenic Aspects of Noninvasive and Invasive Diagnostic Methods in Interventional Cardiology; Chapter 20. Iatrogenicity Associated With Interventional Treatment Modalities in Cardiology; Chapter 21. Iatrogenicity of Diagnostic and Therapeutic, Invasive and Noninvasive Cardiovascular Interventions, Devices, and Surgeries; Chapter 22. Iatrogenic Aspects of Cardiac Electrophysiology; Chapter 23. Iatrogenic Aspects in Cardiac Device Therapy

Chapter 24. Cardiovascular Iatrogenicity of Respiratory Therapeutic ModalitiesPart IV: Iatrogenic Aspects of Sport Cardiology and Lifestyle Modifications; Chapter 25. Trained Athletes; Chapter 26. Sports Cardiology; Chapter 27. Dangers of Lifestyle Modification Advice; Part V. Iatrogenicity of Dietary Supplements, Herbal Products, and Other Nontraditional Therapies in Cardiovascular Medicine; Chapter 28. Safety of Dietary and Herbal Supplements: Side Effects and Contraindications; Chapter 29. Interactions Between Supplements and Medications; Index

Master record variable field(s) change: 072

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice